Intocell is a biotechnology company that develops an antibody-drug conjugate platform for the R&D and commercialization of biopharmaceuticals. Intocell creates protein-drug complexes, antibody-drug complexes, and other complexes with their own linkers and drugs.

Kaihui Technology Development (Shanghai) Co., Ltd., established on 2006-07-13, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);New material technology research and development;Engineering and Technology Research and Experimental Development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

LegoChem Biosciences, Inc. engages in the development, manufacture of medicines, medical devices and medical supplies. It offers medical equipment and therapeutic products such as antibiotics, anti-coagulants, oncology, antibody-drug conjugate, and protein-drug conjugate. The company was founded on May 2, 2006 and is headquartered in Daejeon, South Korea.

Levena Biopharma has built a one-stop-shop for ADCs from inception to clinic and beyond. Over the past 9 years we have developed a full suite of reagents, tools and capabilities to enable our clients and partners with the opportunity to produce best in class antibody drug conjugates.

Akzo Nobel NV is a holding company, which engages in the manufacture and sale of coating and paint products. engages in the production and marketing of paints and coatings. It operates through the following segments: Decorative Paintings, Performance Paintings, and Corporate and Others. The Decorative Paints segment manufactures and supplies a range of interior and exterior decoration and protection products for professional and do-it-yourself markets. The Performance Coatings segment produces automotive and aerospace; industrial; marine and protective; and powder coatings. The company was founded in 1792 and is headquartered in Amsterdam, Netherlands.

Lianning (Suzhou) Biopharmaceutical Co., Ltd., established on 2016-06-02, Business scope includes research and development,Production:medicine,Sell ​​the company's own products.Wholesale of medicines,import and export,commission agent(except auction)and related business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hangzhou Haoyang Biotechnology Co., Ltd. is a private company headquartered in China that provides biotechnological research and development services.

ZymoGenetics is focused on the discovery, development, and early manufacture of therapeutic proteins. ZymoGenetics is a fully-integrated research and development organization with a broad range of skills and technologies, including scientific computing, molecular and cellular biology, protein chemistry, antibody generation and engineering, clinical development and operations, regulatory affairs, quality, drug formulation, process development and protein manufacturing.

Shenzhen Osa Pharmaceutical Co., Ltd., established on 1998-12-15, Business scope includes general business items:Invest in business(Specific projects will be reported separately);Domestic Trade(Does not contain franchise,Exclusive control,Monopoly);Operating import and export business(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating);biomedical technology,Biotechnology research and development and consulting(No restricted items).Cosmetics Retail;General merchandise sales;Sales of agricultural and sideline products;Disinfectant sales(Free of Hazardous Chemicals);Sales of daily chemical products;Cosmetics Wholesale;Retailing of Class II Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:In vitro diagnostic reagents(Except special management diagnostic reagents)promotion of;Chemical API,Wholesale of chemical preparations;one type,Class II,Sales of Class III Medical Devices.Disinfection equipment sales;Healthy food(prepackaged)Sales;food sales;Drug retail;Class III medical device business;Drug Wholesale.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Viela Bio, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatment for autoimmune and inflammatory diseases. The firms product candidate includes inebilizumab, which is a humanized monoclonal antibody (mAb), designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells; VIB4920, which is a fusion protein designed to bind to CD40L on activated T cells, blocking their interaction with CD40-expressing B cells and potentially other binding partners; and VIB7734, which is a humanized mAb intended to be a novel treatment for autoimmune diseases where the pathology is driven principally by overproduction of type I interferons and other cytokines secreted by pDCs. The company was founded on December 11, 2017 and is headquartered in Gaithersburg, MD.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Xishuangbanna Daizanyuan Biotechnology Co., Ltd., established on 2012-02-23, Business scope includes general items:Natural science research and experimental development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;R&D and application of cell technology;Biochemical product technology research and development;Cosmetics Wholesale;Cosmetics Retail;food sales(Only sell prepackaged food);Healthy food(prepackaged)Sales;Sales of agricultural and sideline products;General merchandise sales;Food Internet Sales(Only sell prepackaged food);Primary processing of edible agricultural products;Wholesale of edible agricultural products;Retailing of Edible Agricultural Products;Fresh Fruit Wholesale;Supply Chain Management Services;Personal Hygiene Sales;Wholesale of aquatic products;Aquatic product acquisition;Aquatic product retail;Fresh egg retail;raw nuts,dried fruit sales;Fresh Fruit Retail;Forestry Product Sales;Edible mushroom cultivation;production of agricultural products,Sales,processing,transportation,Storage and other related services;Wholesale Fresh Vegetables;Fresh Vegetable Retail;Network technology service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:food production;food sales;foot bath service;Life beauty service;Food Internet Sales;Snacks(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life sciences, engineering, pharmaceutical, and education industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create micro-and nanoscale structures from a variety of materials on a range of substrates. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop.\nHeadquartered in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 250 patents and applications filed worldwide and licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign.

Beijing Huaanfo Pharmaceutical Research Center Co., Ltd., established on 2003-01-29, Business scope includes pharmacogenomics,predictive medicine,Cancer Genomics,Technology development of new drugs,technology transfer,technical consulting.(Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments.)

RIBOMIC, Inc. engages in the research and development of molecular targeted drugs using Ribonucleic Acid (RNA) aptamers for use in therapeutic fields. It utilizes the Ribomic Aptamer Therapeutics (RiboART) system to discover new drugs that are applicable to target proteins. The company was founded by Yoshikazu Nakamura on August 1, 2003 and is headquartered in Tokyo, Japan.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

NBE-Therapeutics is a privately owned Swiss, Basel-based biotech company that was founded in 2012. It is dedicated to developing cancer therapies to increase survival and improve the quality of life for cancer patients worldwide. The company’s immune-stimulatory therapies are based on a proprietary, highly differentiated Antibody-Drug Conjugate platform. Its ADC platform creates potent and safe immune-stimulatory ADCs with an anthracycline payload, not only directly targeting tumor cells but also inducing a long-lasting immunological anti-tumor effect.

Shanghai Kuailing Biotechnology Co., Ltd., established on 2006-06-02, Business scope includes practicing medicine,Research and development of diagnostic testing reagents for food safety and agriculture, animal husbandry and veterinary use,Packing and compounding,Sales;Biological experiment equipment,Medical equipment,Processing of R&D and production equipment for diagnostic testing reagents,Production,to assemble,Sales,Plastic packaging materials and plastic products(Non-leather,Styrofoam and other items involving toxic raw materials),Diagnostic test strip accessories(Fiber,Film Protective Film Strip,plastic sheet)processing and production,Sales,Engaged in the import and export of goods and technology,Own house rental. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]